Results 81 to 90 of about 6,946 (216)

Efficacy of tadalafil treatment on erectile dysfunction in patients under dutasteride treatment: A prospective non-randomized comparative study

Urology Research and Practice, 2019
Objective: In this study, we aimed to evaluate the efficacy of tadalafil in the management of erectile dysfunction in patients under dutasteride medication for bladder outlet obstruction.
Önder Yaman, Mete Özkıdık, Mehmet İlker Gökce   +2 more
doaj   +1 more source

Washington University Record, May 7, 2009 [PDF]

, 2009
https://digitalcommons.wustl.edu/record/2178/thumbnail ...

core   +1 more source

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer [PDF]

, 2014
Here we report an integrated analysis that leverages data from treatment of genetic mouse models of prostate cancer along with clinical data from patients to elucidate new mechanisms of castration resistance.
Ala, Ugo, Bianconi, Maristella, Bubley, Glenn, Cantley, Lewis C., Clohessy, John G., Cordon-Cardo, Carlos, Epping, Mirjam T., Gerald, William L., Lis, Rosina, Loda, Massimo, Lunardi, Andrea, Mazzucchelli, Roberta, Montironi, Rodolfo, Nardella, Caterina, Pandolfi, Pier Paolo, Patnaik, Akash, Salmena, Leonardo, Signoretti, Sabina, Stack, Edward C., Wang, Guocan, Webster, Kaitlyn A.   +20 more
core   +1 more source

Efficacy and Safety of Mesotherapy With 0.5% Minoxidil Versus Topical 2% Minoxidil for Female Androgenetic Alopecia: A Randomized Controlled Trial

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Objective To evaluate the efficacy and safety of mesodermal injection of low‐concentration minoxidil versus topical minoxidil in treating female androgenetic alopecia (FAGA). Methods This single‐blind, randomized, controlled trial enrolled 40 FAGA patients divided into experimental (n = 20) and control groups (n = 20).
Xiaodan Wang, Wenjia Weng, Zhenzhen Yan, Juan Li, Bing Bing Song, Wei Zhu, Aditya Gupta   +6 more
wiley   +1 more source

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases

The World Journal of Men's Health
Purpose: Finasteride and dutasteride are used to treat benign prostatic hyperplasia (BPH) and reduce the risk of developing prostate cancer. Finasteride blocks only the type 2 form of 5-alpha-reductase, whereas dutasteride blocks both type 1 and 2 forms
Dae Yul Yang, Won-Woo Seo, Rae Woong Park, Sang Youl Rhee, Jae Myung Cha, Yoon Soo Hah, Chang Won Jeong, Kyung-Jin Kim, Hyeon-Jong Yang, Do Kyung Kim, Ji Yong Ha   +10 more
doaj   +1 more source

Prostate cancer: alcohol, cancer and 5α-reductase inhibitors-is there a link? [PDF]

, 2014
Two major trials have been performed to determine the effect of 5α-reductase inhibitors on subsequent diagnoses of prostate cancer. Both trials showed that high alcohol intake significantly increased prostate cancer risk among men allocated to the ...
Gomella, Leonard G
core   +1 more source

Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women [PDF]

, 2013
BACKGROUND: There is no consensus on the standard treatment options for female pattern androgenetic alopecia (AGA). Efficacy of finasteride in women is controversial. The purpose of this study was to evaluate the clinical efficacy and safety of 5 mg/day
André, MC, Correia, MP, Maia e Silva, J, Oliveira-Soares, R   +3 more
core   +1 more source

Long‐Term Efficacy and Safety of Low‐Level Laser Therapy for Androgenetic Alopecia: A 12‐Month Prospective Trial

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Low‐level laser therapy (LLLT) has emerged as a nonpharmacologic intervention for androgenetic alopecia (AGA), but evidence on its long‐term efficacy remains limited. Objective To evaluate the 12‐month effectiveness and safety of a home‐use helmet‐type LLLT device in individuals with AGA.
Jung-Won Shin, Kyungho Paik, Jung-Im Na, Bark-Lynn Lew, Chang-Hun Huh, Yung-Tsu Cho   +5 more
wiley   +1 more source

PERBEDAAN KADAR PSA DAN TGF-β1 TERHADAP PEMBERIAN KOMBINASI INHIBITOR 5α-REDUKTASE (DUTASTERIDE) DAN ANTI ESTROGEN (TAMOXIFEN) PADA PASIEN BPH LUTS

Jurnal Urologi Indonesia, 2016
Objective: To compare the PSA and TGF-β1 plasma level before and after administration of a 5α-reductase inhibitor (dutasteride) and an anti estrogen (tamoxifen) in nonobstructive patients with BPH.
Rachmat Budi Prasetyo, Soetojo Soetojo, Doddy M Soebadi   +2 more
doaj   +1 more source

Polycystic ovary syndrome: a dermatologic approach [PDF]

, 2011
Polycystic ovary syndrome (POS) is one of the most common endocrine abnormalities affecting women of reproductive age. It is a cause of significant social embarrassment and emotional distress.
Bagatin, Edileia, Costa, Dailana Louvain Marinho, Manela-azulay, Mônica, Moura, Heloisa Helena Gonçalves De, Sodré, Celso Tavares   +4 more
core   +3 more sources